This study examines how BRCA gene mutation status affects survival in early-stage breast cancer. Patients over 18 with histologically confirmed early invasive breast cancer who received neoadjuvant and/or adjuvant chemotherapy were included. It was carried out as a study with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Patients older than 18 years old, * Histologically confirmed invasive early breast cancer * Neo-adjuvant and/or adjuvant chemotherapy with the first cure of chemotherapy received between January 1st, 2003 and December 31th, 2013 Exclusion Criteria: * Clinical, radiological or histological confirmed metastatic disease * Non-invasive breast cancer, * Patients who received incomplete treatment * Patients who did not speak French